New Results
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian Cancer
Yu Rebecca Miao, Kaushik N. Thakkar, Jin Qian, Mihalis S. Kariolis, Huang Wei, Saravanan Nandagopal, Teddy Yang, Anh N. Diep, Gerald Maxwell Cherf, Yu Xu, Eui Jung Moon, Yiren Xiao, Haizea Alemany, Tianer Li, Wenhua Yu, Bo Wei, Erinn B. Rankin, Amato J. Giaccia
doi: https://doi.org/10.1101/2020.01.19.911941
Yu Rebecca Miao
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Kaushik N. Thakkar
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Jin Qian
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
2Department of Obstetrics and Gynecology, Stanford School of Medicine, Stanford, CA, U.S.A
Mihalis S. Kariolis
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Huang Wei
3ChemPartner Shanghai, Shanghai, China
Saravanan Nandagopal
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Teddy Yang
3ChemPartner Shanghai, Shanghai, China
Anh N. Diep
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Gerald Maxwell Cherf
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Yu Xu
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Eui Jung Moon
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Yiren Xiao
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
2Department of Obstetrics and Gynecology, Stanford School of Medicine, Stanford, CA, U.S.A
Haizea Alemany
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Tianer Li
4Department of Biochemistry, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Wenhua Yu
4Department of Biochemistry, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Bo Wei
5China PLA General Hospital, Beijing, China
Erinn B. Rankin
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
2Department of Obstetrics and Gynecology, Stanford School of Medicine, Stanford, CA, U.S.A
Amato J. Giaccia
1Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, U.S.A
Posted January 20, 2020.
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian Cancer
Yu Rebecca Miao, Kaushik N. Thakkar, Jin Qian, Mihalis S. Kariolis, Huang Wei, Saravanan Nandagopal, Teddy Yang, Anh N. Diep, Gerald Maxwell Cherf, Yu Xu, Eui Jung Moon, Yiren Xiao, Haizea Alemany, Tianer Li, Wenhua Yu, Bo Wei, Erinn B. Rankin, Amato J. Giaccia
bioRxiv 2020.01.19.911941; doi: https://doi.org/10.1101/2020.01.19.911941
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian Cancer
Yu Rebecca Miao, Kaushik N. Thakkar, Jin Qian, Mihalis S. Kariolis, Huang Wei, Saravanan Nandagopal, Teddy Yang, Anh N. Diep, Gerald Maxwell Cherf, Yu Xu, Eui Jung Moon, Yiren Xiao, Haizea Alemany, Tianer Li, Wenhua Yu, Bo Wei, Erinn B. Rankin, Amato J. Giaccia
bioRxiv 2020.01.19.911941; doi: https://doi.org/10.1101/2020.01.19.911941
Subject Area
Subject Areas
- Biochemistry (11739)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17409)
- Clinical Trials (138)
- Developmental Biology (9419)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12238)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28068)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)